Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?

Author:

Catalano AlessiaORCID,Iacopetta DomenicoORCID,Ceramella JessicaORCID,Maio Azzurra Chiara De,Basile Giovanna,Giuzio Federica,Bonomo Maria GraziaORCID,Aquaro StefanoORCID,Walsh Thomas J.,Sinicropi Maria StefaniaORCID,Saturnino CarmelaORCID,Geronikaki AthinaORCID,Salzano Giovanni

Abstract

The beginning of the end or the end of the beginning? After two years mastered by coronavirus disease 19 (COVID-19) pandemic, we are now witnessing a turnaround. The reduction of severe cases and deaths from COVID-19 led to increasing importance of a new disease called post-COVID syndrome. The term post-COVID is used to indicate permanency of symptoms in patients who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Immune, antiviral, antimicrobial therapies, as well as ozone therapy have been used to treat COVID-19 disease. Vaccines have then become available and administered worldwide to prevent the insurgence of the disease. However, the pandemic is not over yet at all given the emergence of new omicron variants. New therapeutic strategies are urgently needed. In this view, great interest was found in nutraceutical products, including vitamins (C, D, and E), minerals (zinc), melatonin, probiotics, flavonoids (quercetin), and curcumin. This review summarizes the role of nutraceuticals in the prevention and/or treatment of COVID-19 disease and post-COVID syndrome.

Funder

Ministry of Education, Universities and Research

Publisher

MDPI AG

Subject

Plant Science,Health Professions (miscellaneous),Health (social science),Microbiology,Food Science

Reference239 articles.

1. Coronavirus Disease 2019–COVID-19

2. A Multidisciplinary Approach to Coronavirus Disease (COVID-19)

3. Risks of novel Coronavirus Disease (COVID-19) in pregnancy; a narrative review;Panahi;Arch. Acad. Emerg. Med.,2020

4. WHO Virtual Press Conference on COVID-19–11 March 2020 https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2

5. WHO Coronavirus (COVID-19) Dashboard http://covid19.who.int

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3